Gujarat Terce Laboratories Ltd

Gujarat Terce Laboratories Ltd (GUJTERC) is a micro-cap Healthcare company valued at ₹27 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

Gujarat Terce Laboratories Ltd last traded at ₹34.83, sharply down 5.04% on the day.

Recent developments

On 2026-09-30, promoter holding was reported at 40.03%, showing no change from the previous quarter. No recent developments were reported in the last quarter.

Financial performance

The company's annual revenue fell 5.4% to ₹47 crore, while net profit swung from a loss of ₹1 crore to a profit of ₹2 crore. The latest quarter showed a revenue drop of 17.1% to ₹9 crore, with a net loss of ₹0 crore, widening from the previous quarter's ₹0 crore loss.

Valuation multiples

The stock trades at 11.9 times earnings, a discount to the Healthcare median of 32.0, 3.28 times book value.

Things to watch

The latest quarter's net profit widened from a loss of ₹0 crore to a loss of ₹0 crore, indicating no improvement in profitability. The stock is 26.6% below its 52-week high, and the company's revenue growth has slowed significantly in the last year.

Where it stands

The company's net profit margin improved by 6.6 percentage points to 4.6%, but the latest quarter's revenue and net profit figures show no progress. The most significant movement was the swing from a net loss to a profit in the annual results, while the stock remains far below its recent peak.

Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.